Levosimendan: implications for clinicians.

Levosimendan: implications for clinicians.

Item
http://www.wikidata.org/entity/Q35546635
One problem two issues! Left ventricular systolic and diastolic dysfunction in aortic stenosisEffects of serial levosimendan infusions on left ventricular performance and plasma biomarkers of myocardial injury and neurohormonal and immune activation in patients with advanced heart failureLevosimendan: a novel inotropic agent for treatment of acute, decompensated heart failure.Levosimendan for the treatment of acute heart failure syndromes.Effects of levosimendan/furosemide infusion on plasma brain natriuretic peptide, echocardiographic parameters and cardiac output in end-stage heart failure patients.Effectiveness of prophylactic levosimendan in high-risk valve surgery patients.Cardiogenic shock after primary percutaneous coronary intervention: Effects of levosimendan compared with dobutamine on haemodynamics.Haemodynamic effects of levosimendan in advanced but stable chronic heart failure.
P2860

Levosimendan: implications for clinicians.

Item
http://www.wikidata.org/entity/Q35546635
description
2003 nî lūn-bûn
@nan
2003 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Levosimendan: implications for clinicians.
@ast
Levosimendan: implications for clinicians.
@en
type
label
Levosimendan: implications for clinicians.
@ast
Levosimendan: implications for clinicians.
@en
prefLabel
Levosimendan: implications for clinicians.
@ast
Levosimendan: implications for clinicians.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P577
P698
P356
P1433
P1476
Levosimendan: implications for clinicians.
@en
P2093
P2860
P304
P31
P356
P433
P478
P577
P698